Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Autoimmune Encephalitides (AE) involve antibodies targeting neuronal surface antigens.
• N-Methyl-D-Aspartate (NMDA) receptor encephalitis is the most common subtype, with numerous other receptor and surface protein antibodies identified.
• These conditions often manifest as limbic encephalitis with cognitive, psychiatric, and seizure symptoms.

Purpose of the Study:

• To review current knowledge on autoimmune encephalitides.
• To detail subtype-specific clinical presentations, mechanisms, diagnosis, and treatment.
• To provide insights into prognosis and future research directions.

Main Methods:

• Review of current literature on autoimmune encephalitides.
• Analysis of subtype-specific clinical features and antibody targets.
• Synthesis of diagnostic approaches and treatment paradigms.

Main Results:

• AEs are characterized by a growing list of antibodies against neuronal targets.
• Clinical presentations vary, often including limbic encephalitis features.
• AEs are generally responsive to immunotherapy, with outcomes dependent on early diagnosis and treatment intensity.

Conclusions:

• Autoimmune encephalitides require prompt diagnosis and aggressive immunotherapy for favorable outcomes.
• Understanding subtype-specific features is crucial for effective management.
• Further research is needed to refine treatment strategies and understand disease mechanisms.